TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07881926: Performance and Safety Evaluation of the MD60002 Device in the Treatment of Skin Imperfections Due to Aging

Sponsor: Promoitalia Group Spa · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 43 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,256,000

Rescue Site Savings

+$5,443,800

Unlock Full NCT07881926 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07881926 Rescue Dossier →